Broadly Neutralizing SARS-CoV-2 Antibodies through Epitope-Based Selection from Convalescent Patients

Researchers demonstrated that broadly neutralizing antibodies could be isolated from peripheral blood mononuclear cells of convalescent patients using SARS-CoV-2 receptor binding domains carrying epitope-specific mutations.